Cannasat, IntelGenx deal

IntelGenx signed a letter of intent to acquire a 50% stake in Relivar, a sublingual tablet formulation of dronabinol (delta-9-tetrahydrocannabinol, THC). Under the letter, IntelGenx also would receiv...